Merck announced the acquisition of Verona Pharma plc, a development discussed by Jim Cramer in the context of AI stock benefits from tariffs.
2 reports, 1 independent
Updated Jul 13
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Merck announced the acquisition of Verona Pharma plc, a development discussed by Jim Cramer in the context of AI stock benefits from tariffs.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Merck announced acquisition of Verona Pharma; Jim Cramer discussed the matter.1 source
- Pending acquisition of Verona Pharma by Merck amidst impacts from Trump's tariff policies.
Keep exploring
The entities involved
-
Verona Pharma
company in London, United Kingdom
Nothing else this week.
-
Jim Cramer
American stockbroker, television personality, author
-
Merck
public company in Indonesia
Related events
- Jim Cramer discussed AMC stock performance, noting that the company benefits from Trump-era tariffs and onshoring.
- Cramer discussed CVS's turnaround efforts, noting that the company benefits from Trump-era tariffs.
- Cramer discussed Bitcoin investment strategy and Galaxy Digital's platform for digital asset trading, while tariffs benefit AI stocks.
Coverage
Newest first; wire copies grouped- Insider MonkeyVerona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Verona Pharma plc (NASDAQ:VRNA) is on
- Unknown outlet